Archives

Perspective: Age in the Age of COVID-19

2 Sep, 2020 | 09:45h | UTC

Age in the Age of COVID-19 – Think Global Health

 

---

#ESCCongress – [Not Published Yet] Randomized trial on transfusion thresholds in anemic heart attack patients

2 Sep, 2020 | 09:42h | UTC

News Release: Trial clarifies use of blood transfusion in anaemic heart attack patients – European Society of Cardiology

Commentary: Randomized Trial of Transfusion Strategies in Patients With Myocardial Infarction and Anemia – REALITY – American College of Cardiology

 

---

Guideline synopsis: The diagnosis and management of hypertension in the primary care setting

2 Sep, 2020 | 09:38h | UTC

Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: The Diagnosis and Management of Hypertension in the Primary Care Setting – Annals of Internal Medicine

 

---

[Abstract Only] Randomized trial: Effect of High add power, medium add power, or single-vision contact lenses on myopia progression in children

2 Sep, 2020 | 09:33h | UTC

Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial – JAMA

Commentaries: Multifocal contact lenses slow myopia progression in children – NIH News Releases AND Young nearsighted kids benefit from bifocal contact lenses, study shows – Ohio State University

 

---

Pulmonary hypertension: A brief guide for clinicians

2 Sep, 2020 | 09:34h | UTC

Pulmonary Hypertension: A Brief Guide for Clinicians – Mayo Clinic Proceedings

 

---

The mosquito strategy that could eliminate dengue

2 Sep, 2020 | 09:36h | UTC

The mosquito strategy that could eliminate dengue – Nature

 

Commentary on Twitter

A randomized field trial found that Wolbachia-infected mosquitoes reduced cases of dengue by an "extraordinary" 77%.https://t.co/7lfLkPOLFO

— nature (@Nature) September 1, 2020

 

---

COVID-19 Updates / 01 September 2020 Edition

1 Sep, 2020 | 03:46h | UTC

02 September 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives

 

Coronavirus Tracked: The Latest Figures

• Coronavirus tracked: the latest figures as the pandemic spreads – Financial Times
• Johns Hopkins Coronavirus Interactive Map
• Coronavirus Map: Tracking the Global Outbreak – The New York Times
• Coronavirus Disease (COVID-19) – Statistics and Research – Our World in Data
• The Covid-19 Tracker – STAT
• WHO: Latest COVID-19 Situation Report – Weekly Epidemiological Update

New #OpenWho Course: Occupational health and safety for health workers in the context of COVID-19 Read more >

---

Position Paper: Diagnosis and treatment of pulmonary embolism during the COVID-19 pandemic

1 Sep, 2020 | 06:27h | UTC

Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium – CHEST

 

---

Systematic review: Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis

2 Sep, 2020 | 09:30h | UTC

Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis – Cochrane Library

Summary: Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis – Cochrane Library

 

---

[Abstract Only] Randomized trial: Second-look surgery plus hyperthermic intraperitoneal chemotherapy vs. surveillance in patients at high risk of developing colorectal peritoneal metastases

2 Sep, 2020 | 09:31h | UTC

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study – The Lancet Oncology

Commentary: Second-Look Surgery Plus HIPEC vs Surveillance for Patients at High Risk for Colorectal Peritoneal Metastases – The ASCO Post

 

---

Anticoagulation in COVID-19: A systematic review, meta-analysis and rapid guidance from the Mayo Clinic

1 Sep, 2020 | 06:26h | UTC

Anticoagulation in COVID-19: A Systematic Review, Meta-Analysis and Rapid Guidance From The Mayo Clinic – Mayo Clinic Proceedings

 

---

In WHO global pulse survey, 90% of countries report disruptions to essential health services since COVID-19 pandemic

1 Sep, 2020 | 06:29h | UTC

In WHO global pulse survey, 90% of countries report disruptions to essential health services since COVID-19 pandemic – World Health Organization

Original report: Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020 – World Health Organization

 

---

Cases of SARS-CoV-2 reinfection highlight the limitations — and the mysteries — of our immune system

1 Sep, 2020 | 06:18h | UTC

Cases of SARS-CoV-2 Reinfection Highlight the Limitations — and the Mysteries — of Our Immune System – HIV and ID Observations

 

---

Practical guidance for tracheal intubation of patients with COVID-19

1 Sep, 2020 | 06:23h | UTC

Practical Guidance for Tracheal Intubation of Patients With COVID-19 – Mayo Clinic Proceedings

 

---

Asthma in COVID-19 hospitalizations: An overestimated risk factor?

1 Sep, 2020 | 06:22h | UTC

Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor? – Annals of the American Thoracic Society

Commentary: Asthma May Not Be a Significant Risk Factor for Severe COVID-19 or COVID-Related Intubation – American Thoracic Society

 

Commentary on Twitter

https://twitter.com/holguinf01/status/1300505812473843713

 

---

CDC Study: SARS-CoV-2 infections often go undetected in health care workers

1 Sep, 2020 | 06:16h | UTC

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020 – CDC Morbidity and Mortality Weekly Report

Commentary: CDC: Nearly 30% of health workers with COVID-19 didn’t know they had it – UPI

 

Commentary on Twitter

A new @CDCMMWR finds many #COVID19 infections among healthcare workers appear to go undetected, likely because many people infected with the virus that causes COVID-19 have mild or no symptoms. Learn more: https://t.co/VOKbZil9ob. pic.twitter.com/bnTAcmIzr9

— CDC (@CDCgov) August 31, 2020

 

---

Scientists are reporting several cases of Covid-19 reinfection — but the implications are complicated

1 Sep, 2020 | 06:20h | UTC

Scientists are reporting several cases of Covid-19 reinfection — but the implications are complicated – STAT

 

---

Low risk of COVID-19 among patients exposed to infected healthcare workers

1 Sep, 2020 | 06:14h | UTC

Low risk of COVID-19 among patients exposed to infected healthcare workers – Clinical Infectious Diseases

 

Commentary on Twitter

Low risk of COVID-19 among patients exposed to infected healthcare workers | #CID The risk of acquiring #SARSCoV2 from an infected HCW was low in a study that tested patients exposed to 60 HCWs with unrecognized SARS-CoV-2 infection. https://t.co/4hppyoXSLC

— Carlos del Rio (@CarlosdelRio7) September 1, 2020

 

---

What Is the predictive value of a single nasopharyngeal SARS-CoV-2 PCR swab test in a patient with COVID-like symptoms and / or significant COVID-19 exposure?

1 Sep, 2020 | 06:12h | UTC

What Is the Predictive Value of a Single Nasopharyngeal SARS-CoV-2 PCR Swab Test in a Patient with COVID-like Symptoms and / or Significant COVID-19 Exposure? – Open Forum Infectious Diseases

 

Commentary on Twitter

What Is the Predictive Value of a Single Nasopharyngeal SARS-CoV-2 PCR Swab Test in a Patient with COVID-like Symptoms and / or Significant #COVID19 Exposure?
The PCR-test was found to be 87% sensitive, 97% specific, a PPV of 0.98, and a NPV of 0.80 #ofid https://t.co/MGQdzDsd8k

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 31, 2020

 

---

Viewpoint – Regulatory decision-making on COVID-19 vaccines during a public health emergency

1 Sep, 2020 | 06:08h | UTC

Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency – JAMA

 

---

Viewpoint – Emergency use authorizations during the COVID-19 pandemic: Lessons from hydroxychloroquine for vaccine authorization and approval

1 Sep, 2020 | 06:09h | UTC

Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval – JAMA

 

---

A current review of COVID-19 for the cardiovascular specialist

1 Sep, 2020 | 06:06h | UTC

A current review of COVID-19 for the cardiovascular specialist – American Heart Journal

 

---

#ESCCongress – [Abstract Only] Randomized trial: Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome

1 Sep, 2020 | 06:03h | UTC

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial – The Lancet

Commentary: Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial – Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients – HOST-REDUCE-POLYTECH-ACS – American College of Cardiology

 

Commentary on Twitter

Late breaking at #ESCCongress—Prasugrel-based de-escalation of dual antiplatelet therapy after PCI in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial https://t.co/yvcdB4rZ9x pic.twitter.com/GhPfztHwMX

— The Lancet (@TheLancet) August 31, 2020

 

---

Perspective: How to be an ethical scientist

1 Sep, 2020 | 05:55h | UTC

How to be an ethical scientist – Science

 

---

Factors associated with risk of recurrent transient global amnesia

1 Sep, 2020 | 05:53h | UTC

Factors Associated With Risk of Recurrent Transient Global Amnesia – JAMA Neurology (free for a limited period)

 

---